ID   L1210/DDPt
AC   CVCL_E2YG
RX   PubMed=3664938;
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=3664938; DOI=10.1007/BF00253961;
RA   Wilkoff L.J., Dulmadge E.A., Trader M.W., Harrison S.D. Jr.,
RA   Griswold D.P. Jr.;
RT   "Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV)
RT   in murine leukemia L1210 resistant and sensitive to
RT   cis-diamminedichloroplatinum (II).";
RL   Cancer Chemother. Pharmacol. 20:96-100(1987).
//